Stay updated on I-SPY Trial: Personalized Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the I-SPY Trial: Personalized Breast Cancer Clinical Trial page.

Latest updates to the I-SPY Trial: Personalized Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedA medRxiv preprint by Magbanua et al. on circulating tumor DNA as a prognostic factor in neoadjuvant breast cancer therapy was added to the Publications list, expanding the study's biomarker references.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now shows a 500 error page with a minimal HTML structure. The original study content and navigation were removed, leaving the page unavailable.SummaryDifference25%

- Check24 days agoChange DetectedA new publication citation has been added to the Publications section, listing authors and the JAMA Oncol article on Cemiplimab and Fianlimab with neoadjuvant chemotherapy in early-stage high-risk ERBB2-negative breast cancer (I-SPY2). This update expands the study's referenced literature and documents ongoing dissemination of trial findings.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, representing a new page build. It does not change the displayed information or user experience.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, reflecting a new deployment/version of the page.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision tag on the page updated from v3.6.0 to v3.6.2, indicating a newer build of the ClinicalTrials.gov page. No substantive content changes are indicated by this revision.SummaryDifference0.0%

Stay in the know with updates to I-SPY Trial: Personalized Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the I-SPY Trial: Personalized Breast Cancer Clinical Trial page.